Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Repaglinide (Oral Route)
A phase III study comparing the efficacy and safety of DFMO in combination with lomustine versus lomustine alone in patients with recurrent/progressive anaplastic astrocytoma following radiotherapy and temozolomide chemotherapy is also underway (NCT02796261)
Interleukin-1-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression
The kind of results that come from actual cellular repair, not masking
US$ 22.01
US$ 23.01
US$ 29.92
US$ 27.55
